Partnership between Ozyme and Slingshot whose expertise is the development of synthetic cells capable of accurately reproducing the biochemical and fluorescent characteristics of cells.
⁃ ViaComp®: single control to compensate for viability markers (DNA intercalators or reagents binding to primary amines)
Scipio bioscience, a French company, has developed an integrated RNA sequencing solution at the single cell scale.
Scipio bioscience offers an instrument-free, accessible solution for your single-cell RNA-seq experiments. The Asteria benchtop kit enables you to profile up to 10,000 cells simultaneously thanks to a revolutionary hydrogel technology, and Cytonaut is an intuitive, entirely cloud-based software covering the entire single-cell analysis process.
Navinci has developed a "Proximity Ligation" technological platform to analyze and quantify proteins in situ at the molecular level in the natural environment of the cell:
• Detection of protein-protein interactions
• Specific detection of post-translational modifications
• Ability to detect extremely low abundance proteins, without overexpressing the protein of interest
• Analysis directly in a single cell or within a tissue (diseased or tumourous)
Applications: Immuno-profiling, signalling profiling, drug testing, treatments validation, biomarkers discovery, etc.
Proximity Ligation technology provides better sensitivity and specificity than PLA technology
The Austrian company specializes in particular in transcriptome profiling solutions and the analysis of NGS data.
Some of the exclusive technologies developed by Lexogen include:
• QuantSeq 3‘ mRNA-Seq Library Prep : preparation of mRNA-Seq 3’ libraries
• RiboCop rRNA Depletion : efficient depletion of ribosomal RNAs upstream of NGS
• CORALL Total RNA-Seq Library Prep : preparation of “whole transcriptome” libraries
Codex DNA's mission is to equip scientific researchers with the necessary methodologies to quickly and accurately produce large quantities of synthetic genes. Ozyme completes its offering on cloning solutions by integrating products from Codex DNA, a company co-founded by Dan Gibson, the inventor of Gibson cloning technology recognized as the gold standard, into its catalog.
Gibson Assembly® kits are the most recent versions generating the best cloning efficiency.
The product portfolio also includes Vmax ™ competent cells for the production of proteins in bacteria. This system makes it possible to generate significantly larger quantities of biomass than traditional systems for the expression of bacterial proteins.
Ozyme completes its antibody offering by including Jackson Immuno Research (JIR), a recognized specialist in secondary antibodies, in its catalog.
Jackson Immuno Research is an American company of more than 35 years specialized in the production and the purification of secondary antibodies conjugated to a large choice of fluorophores, enzymes (HRP, PA) or gold beads validated for a large number of applications (IF, FC, IHC, ELISA, WB, electron microscopy…).
Corning is a company developing new tools and technologies for researchers in the life sciences. Their R&D experts meet the growing need for reliable reagents for cell culture. It is this expertise, added to 160 years of innovation and excellence, that positions Corning to offer a complete portfolio of high-quality media and consumables in cell culture.
Ozyme signs an agreement with the company Integrated DNA Technologies for the marketing of high quality reagents in genomics, and in particular:
Integrated DNA Technologies is the world leader in the manufacturing of custom oligonucleotides for academic laboratories, medical diagnostics, biotechnology companies, agriculture and pharmaceutical development.
Partnership between Ozyme and Azure Biosystems for the range of imagers (gels and Western blot) and scanners
Ozyme expands its offer for Western Blot and IP by marketing the antibodies of Bethyl Laboratories, Inc. This range represents more than 19,000 references of antibodies for WB, IP and also ELISA and IHC in cancer, cardiovascular system, cell biology, immunology, neurobiology and signal transduction.